An “immune system reset” eliminated autoimmune, or Type 1, diabetes in mice in a study conducted at. Researchers say the strategy could also have potential for treating other autoimmune diseases and ...

This summer, Norton Healthcare hopes to launch a new islet cell program to help treat chronic pancreatitis and eventually ...

IBM and JDRF, a New York City-based organization that funds Type 1 diabetes research, will apply machine learning algorithms to investigate existing Type 1 diabetes research datasets. Under the ...

Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks the cells that produce insulin—a critical hormone that regulates blood sugar in the body. Scientists at Scripps ...

Researchers at UChicago have developed a nanoparticle system that can effectively deliver mRNA to insulin-producing cells, protecting them from the body’s autoimmune response ...

A test using genetics to predict who is at the highest risk of developing type 1 diabetes could one day be applied to largescale health studies, to identify adults who could benefit from new drugs, ...

Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, has launched its 2026 Breakthrough T1D Walks throughout the U.S. to bring the community ...

Sarah Marriott, who lives with Type 1 diabetes, argues that research must ensure equal access to new technologies.

A Garvan-led clinical trial has found that using a common and inexpensive type 2 diabetes drug reduces insulin needs in type 1 diabetes, opening doors for improved management of the condition. For ...

Many Type 1 diabetes clinical trials require that those enrolling be within six months of their Type 1 diabetes diagnosis. This can limit the number of eligible individuals who can participate in the ...